Contrast Agents for Enhanced Bioimaging: A Comprehensive Review.

Authors

Paulo Sérgio Taube, Donald Fernandes, Arthur Abinader Vasconcelos, Hugo de Campos Braga, Alan Kelbis Oliveira Lima, José Arnaldo Santana Costa, Karla Furtado Andriani, Ester da Cunha Meira Santos, Antonio Jorge Silva Araújo Junior, Hauster Maximiler Campos de Paula, Wallace Júnio Reis, Kashif Gul, Nida Wahab, Luis Carlos Resio, Elisa Kawana Leal Dos Santos, Márcio Peres de Araujo, Matheus Allen P da Silva, Juliana Paula da Silva

Published in

Chembiochem : a European journal of chemical biology. Volume 27. Issue 13. Pages e70418. Jul 14, 2026.

Abstract

Nanotechnology has significantly boosted analytical methods capable of visualizing and characterizing materials at the nanoscale, enabling disease monitoring with high precision. These advances have become particularly relevant in biomedical research, where the demand for enhanced diagnostic tools continues to grow. In this context, contrast agents (CAs) have emerged as essential components in modern imaging techniques, driving efforts toward the development of safer, more efficient, and selective diagnostic materials. The growth in the development of CAs reflects the expansion of applications in imaging modalities. Treatment techniques have benefited from nanotechnology innovations in recent decades, while advancements in imaging modalities demonstrate the demand for next-generation CAs with enhanced resolution and sensitivity. Nanomaterials play a central role in this progress, offering high surface area, adjustable porosity, structural stability, and easy functionalization, for drug delivery and disease monitoring. Hybrid nanoparticles, including core-shell systems, clustered architectures, and nanocomposites integrating metallic or magnetic materials with mesoporous silica, zeolites, or metal-organic frameworks (MOFs), allow control of magnetic relaxivity, X-ray attenuation, optical response, and biological interactions. Molecular scale and nanosized materials contribute to improved contrast, targeted delivery, and enhanced biocompatibility in bioimaging. Together, these advances highlight the potential of nanotechnology to transform biomedical diagnostics and disease detection.

PMID:
42376707
Bibliographic data and abstract were imported from PubMed on 30 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.